NEW YORK, July 26- Invitrogen announced a significant increase in second quarter revenues relative to the year ago period, largely due to the contribution of its newly acquired company, Life Technologies, the company announced on Thursday.

Invitrogen also posted a net loss of $35.1 million, or 67 cents per share, during this latest financial period, compared to a net income of $4.8 million in the second quarter, 2000.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.